Merck's molnupiravir has been used in Israel and other countries since late 2021 to treat symptomatic patients with risk factors that could lead to hospitalization or death

First shipment expected to arrive in coming days; ministry doesn't specify numbers or price but report says there will be enough for several thousand treatments at $700 a pop

Tablet developed by Merck known as molnupiravir found to halve rate of hospitalizations and deaths in high-risk Covid patients; not recommended for pregnant women

British health secretary hails approval of Merck's molnupiravir as a 'historic day,' says country looking to start national study on treatment 'as soon as possible'

Bennett reportedly makes announcement to coronavirus cabinet; if cleared, molnupiravir would be 1st pill shown to treat coronavirus patients, a potentially major advance